New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
10:41 EDTRH, JD, FIO, NSR, OPEN, LULU, NWBO, ULTA, MONT, OREXOptions with decreasing implied volatility
Options with decreasing implied volatility: OREX MONT ULTA NWBO LULU OPEN NSR FIO JD RH
News For OREX;MONT;ULTA;NWBO;LULU;OPEN;NSR;FIO;JD;RH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 23, 2014
09:13 EDTMONTMontage Technology receives NASDAQ extended stay
Montage Technology announced that on October 21, the company received a letter from The NASDAQ Stock Market indicating that, pursuant to a request submitted by the company on October 8, the Nasdaq Hearings Panel has granted the company's request to extend the automatic 15-day stay of suspension of trading in the company's ordinary shares pending the hearing on the merits of the company's appeal scheduled for November 6 and a final determination regarding the company's listing status thereafter. The company plans to provide an update regarding its continued listing on NASDAQ once a decision has been issued by the Panel.
October 22, 2014
15:27 EDTLULUlululemon management to meet with William Blair
Subscribe for More Information
04:57 EDTLULUlululemon partners with Dalai Lama Center
Subscribe for More Information
October 21, 2014
10:00 EDTJDOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:09 EDTJDJD.com initiated with a Neutral at Citigroup
Subscribe for More Information
October 20, 2014
08:08 EDTOREXOrexigen and Takeda announce availability of Contrave tablets for patients
Takeda Pharmaceutical, its wholly-owned subsidiary Takeda Pharmaceuticals U.S.A. and Orexigen Therapeutics jointly announced that Contrave extended-release tablets are now available to patients by prescription in pharmacies across the U.S.. Contrave is approved by the FDA as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater, or 27 kg/m2 or greater in the presence of at least one weight-related comorbid condition.
October 16, 2014
10:01 EDTRHOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:01 EDTLULUOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Akamai (AKAM) downgraded to Market Perform from Outperform at Wells Fargo... CGG SA (CGG) downgraded to Reduce from Neutral at Nomura... Central Valley Community (CVCY) downgraded to Hold from Buy at Sandler O'Neill... DSM (RDSMY) downgraded to Neutral from Buy at Nomura... Disney (DIS) downgraded at Guggenheim... Francesca's (FRAN) downgraded to Underperform from Outperform at Macquarie... Netflix (NFLX) downgraded to Fair Value from Buy at CRT Capital... Nordstrom (JWN) downgraded to Neutral from Outperform at Macquarie... Norfolk Southern (NSC) downgraded at Credit Suisse... Rio Tinto (RIO) downgraded to Market Perform at Cowen... Seadrill (SDRL) downgraded to Reduce from Neutral at Nomura... Ternium (TX) downgraded to Neutral from Overweight at JPMorgan... Urban Outfitters (URBN) downgraded to Neutral from Outperform at Macquarie... Viacom (VIAB) downgraded at BofA/Merrill... eBay (EBAY) downgraded to Underperform from Buy at CLSA... lululemon (LULU) downgraded to Underperform from Neutral at Macquarie.
07:21 EDTRHRestoration Hardware initiated with a Buy at Deutsche Bank
Subscribe for More Information
05:39 EDTLULUlululemon downgraded to Underperform from Neutral at Macquarie
Macquarie downgraded lululemon to Underperform after assuming coverage of the stock saying the company's expansion into Asia and Europe will drive a meaningful increase in spending. The firm lowered its price target for shares to $34 from $40.
October 15, 2014
08:35 EDTOREXOrexigen earned $60M milestone payment from Takeda Pharmaceutical
Subscribe for More Information
07:42 EDTMONTMontage Technology reports preliminary Q3 revenue $46M, consensus $43.1M
Montage Technology Group announced preliminary revenue results for Q3 of approximately $46M, exceeding its previously announced guidance range of $41M-$45M. The increased revenue expectations reflect higher sales of its memory interface solutions, which are expected to be approximately $14M or 30% of revenue for Q3, primarily due to increased demand for its DDR4 RDIMM and LRDIMM solutions.
October 14, 2014
10:27 EDTULTAUlta Salon volatility elevated into investor meeting
Ulta Salon October call option implied volatility is at 47, November is at 33, December is at 42; compared to its 26-week average of 34 according to Track Data, suggesting large near term price movement into an Investor meeting on October 15.
09:08 EDTNWBONorthwest Biotherapeutics begins first treatment with DCVax-L in Germany
Subscribe for More Information
October 13, 2014
14:02 EDTLULUlululemon's Q3 sales tracking below consensus, says ITG Research
Subscribe for More Information
11:53 EDTULTAUlta Salon to host investor meeting
Investor meeting to be held in Chicago on October 15 at 11 am. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use